03.07.2012
- When Roche paid $46.8 billion in 2009 to gain full ownership of Genentech, fears were rife that the arrival of the Swiss men in suits would stifle the free-wheeling innovative...
29.06.2012
- GlaxoSmithKline has once again extended its $2.6 billion offer to buy long-time partner Human Genome Sciences until July 20 as a hostile stand-off with the U.S. biotech company...
25.06.2012
- FivePrime Therapeutics has entered into research and commercial agreements with Biowa and Lonza to use their Potelligent CHOK1SV Cell Line for the research, development and...
20.06.2012
- Sartorius Stedim Biotech (SSB), an international pharma and biotech supplier, and Bosch Packaging Technology (Bosch), a provider of process technology and packaging solutions for...
19.06.2012
- Fujifilm Diosynth Biotechnologies has announced it is further increasing its contract process development and manufacturing capabilities through the expansion of its services in...
15.06.2012
- U.S. biotech company Human Genome Sciences said on Friday it had set a bid date of July 16 for definitive offers to acquire the company and again urged hostile bidder...
14.06.2012
- Competition in the eye drug market is heating up, with an experimental drug from private U.S. biotech Ophthotech showing impressive results when added to Roche's Lucentis in a...
13.06.2012
- U.S. drugmaker Upsher-Smith Laboratories is to buy British group Proximagen for 223 million pounds ($347 million) plus further payments potentially worth up to 134 million based on...
12.06.2012
- Pharma Engineering - While the upheaval in the pharmaceutical industry has brought with it a lot of problems, one sector that is benefiting from the overhaul is pharma engineering...
06.06.2012
- Germany's Merck KGaA and India's Dr. Reddy's Laboratories have struck a deal to develop cheap versions of biotech cancer drugs, seeking to tap into a new market as patents on...
